Site-specific orthogonal bioconjugate modality and application thereof
AssigneeGenequantum Healthcare (Suzhou) Co., Ltd.
InventorsGang QIN, Meijun XIONG, Cao LV, Lili SHI
Life of this patent
Estimating the term…
Abstract
Provided is the process of producing an immunoligand/payload conjugate, in particularly, relates to a novel enzyme site-specific conjugation technology with dual enzyme orthogonal catalysis, comprising: conjugating a first payload to an immunoligand through the enzymatic catalysis of a first enzyme, conjugating a second payload to the immunoligand through enzymatic catalysis of a second enzyme, wherein the first enzyme is different from the second enzyme.
Claims36
An enzymatic conjugation process for preparing an immunoligand/payload conjugate, comprising the following steps:
- conjugating a first payload to an immunoligand through enzymatic catalysis of a first enzyme,
- conjugating a second payload to the immunoligand through enzymatic catalysis of a second enzyme,
- wherein the first enzyme is different from the second enzyme.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.